NanoViricides Inc (NNVC.A)

NNVC.A on American Stock Exchange

22 Aug 2014
Price Change (% chg)

$-0.06 (-1.50%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low


Chart for NNVC.A


NanoViricides, a development-stage company. The Company is a nano-biopharmaceutical (nanomedicine) company whose business goals are to discover, develop and commercialize therapeutics to advance the care of patients suffering from life-threatening viral infections. The Company has several drugs in various stages of early... (more)


Beta: 0.67
Market Cap (Mil.): $214.33
Shares Outstanding (Mil.): 54.54
Dividend: --
Yield (%): --


  NNVC.A Industry Sector
P/E (TTM): -- 139.05 34.44
EPS (TTM): -0.22 -- --
ROI: -39.25 -2.96 18.11
ROE: -49.55 -7.10 18.84
Search Stocks

CORRECTED-U.S./Canada daily earnings hits & misses May 19 - 0800 ET

(Corrects to remove reference to results of NanoViricides Inc, Katanga Mining Ltd and American Capital Senior Floating Ltd. None of the three companies reported results on Monday. The error also appeared in previous versions of Hits & Misses) May 19 - The following U.S.- and Canada-listed companies reported earnings on Monday. This list shows whether they beat, met or missed Wall Street analysts' forecasts. It also shows the difference between analysts' expectations and reported re

19 May 2014

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: MacroRisk Analytics/EconomicInvestor
Provider: Reuters Investment Profile
Provider: ValuEngine, Inc.
Provider: GlobalData
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks